# Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines

> **NCT01076478** · PHASE4 · COMPLETED · sponsor: **Otsuka Pharmaceutical, Inc., Philippines** · enrollment: 47 (actual)

## Conditions studied

- Polyneuropathy

## Interventions

- **DRUG:** Cilostazol

## Key facts

- **NCT ID:** NCT01076478
- **Lead sponsor:** Otsuka Pharmaceutical, Inc., Philippines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2009-11
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2010-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01076478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01076478, "Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01076478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*